PolyPid to Report Second Quarter 2024 Financial Results and Operational Highlights on August 14, 2024

Work in a lab
July 2024

PETACH TIKVA, Israel, July 31, 2024 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that it will report its second quarter 2024 financial results and operational highlights before the

Contact Us

    Your information will be processed in accordance with the Privacy Policy.

    Contact icon